Search filters

List of works by Eva Lion

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

scientific article published on 12 June 2018

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

scientific article published on 21 September 2017

Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.

scientific article published on 9 October 2008

Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.

scientific article

Clinical use of dendritic cells for cancer therapy.

scientific article

Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

scientific article published on 19 October 2019

Correction: Interleukin-15-Induced CD56 Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

scientific article published on 27 April 2019

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

scientific article published on 19 September 2019

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

scientific article published in March 2018

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.

scientific article published on October 2015

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

scientific article published on 22 August 2017

Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers

scientific article published on 01 May 2011

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.

scientific article published on 13 January 2017

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

scientific article published on 07 November 2018

Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy

scientific article

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

scientific article published on 12 April 2015

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

scientific article published on 21 June 2019

Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.

scientific article

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells

scientific article

Human tears reveal insights into corneal neovascularization

scientific article

IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation.

scientific article

Identification of a Wilms' tumor 1-derived immunogenic CD4(+) T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes.

scientific article published on 29 August 2012

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

scientific article published in December 2017

Interferon-α in acute myeloid leukemia: an old drug revisited ⬇️

scientific article published on January 28, 2011

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

scientific article published on 7 May 2015

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

scientific article published on 29 September 2016

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

scientific article

Loading of acute myeloid leukemia cells with poly(I:C) by electroporation.

scientific article published on January 2014

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

scientific article published on 21 June 2017

NK cells: key to success of DC-based cancer vaccines?

scientific article published on 20 August 2012

Natural killer cell immune escape in acute myeloid leukemia.

scientific article published on 26 March 2012

PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity

scientific article published on 11 June 2020

Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs.

scientific article published on 02 October 2014

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC

scientific article

Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.

scientific article

Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production

scientific article published on 07 August 2019

The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses

scientific article published on 18 July 2020

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.

scientific article published on 9 December 2015

Paulina is supported by:

About Paulina

Help